Work

ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449

Year: 2022

Type: article

Source: Journal of Neuro-Oncology

DOI: 10.1007/s11060-022-04193-3

Authors: Andrew E. Sloan, Charles J. Nock, Xiaobu Ye, Robert Buerki, Susan Chang, Glenn Lesser, Andrew Norden, Timothy Cloughesy, Jeffrey Olson, Amber Kerstetter-Fogle, Jeremy Rich, Joy Fisher, Serena Desideri, Naoko Takebe, William Timmer, Stuart Grossman, Michael Prados

Institutions: Piedmont Atlanta Hospital, Piedmont HealthCare, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Johns Hopkins University, Johns Hopkins Medicine, University of California, San Francisco, Wake Forest University Health Sciences, Wake Forest University, Dana-Farber Cancer Institute, University of California, Los Angeles, Emory University, University of Pittsburgh, UPMC Hillman Cancer Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Case Comprehensive Cancer Center, Case Western Reserve University, National Institutes of Health, National Cancer Institute

Awards: Adult Brain Tumor Consortium (ABTC), G1525968632, G741073515, UCLA SPORE in Brain Cancer

OpenAlex ID: W4313312378

FWCI: 1.395

Cites: 34

Cited by: 14

Related to: 10